Therapy
Health
Pharmaceutical

Sarepta Therapeutics

$144.06
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$4.54 (-3.04%) Today
-$0.66 (-0.46%) As of 7:33 PM EDT after-hours

Why Robinhood?

You can buy or sell SRPT and other stocks, options, ETFs, and crypto commission-free!

About SRPT

Sarepta Therapeutics, Inc. Common Stock (DE), also called Sarepta Therapeutics, is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. Read More The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Employees
499
Headquarters
Cambridge, Massachusetts
Founded
1980
Market Cap
11.07B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.06M
High Today
$150.54
Low Today
$144.47
Open Price
$150.32
Volume
1.25M
52 Week High
$165.87
52 Week Low
$95.21

Collections

Therapy
Health
Pharmaceutical
Biopharmaceutical
Biotechnology
Technology
US
North America

SRPT News

Barron'sJul 1

Sarepta Therapeutics Stock Could Capitalize From Pfizer’s Stumble

487
ReutersJun 28

Sarepta surges after Pfizer gene therapy data raises safety concerns

1,588
BloombergJun 28

Street Crowns Sarepta DMD Gene Therapy King After Pfizer Results

313

SRPT Earnings

-$1.68
-$1.21
-$0.75
-$0.28
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 7, After Hours

Popular Stocks

More SRPT News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.